Recent News

• 09.08.2025 - H.C. Wainwright 27th Annual Global Investment Conference
• 09.08.2025 - H.C. Wainwright 27th Annual Global Investment Conference
• 09.02.2025 - Werewolf Therapeutics to Participate in the Upcoming H.C. Wainwright 27th Annual Global Investment Conference
• 09.02.2025 - Werewolf Therapeutics to Participate in the Upcoming H.C. Wainwright 27th Annual Global Investment Conference
• 09.02.2025 - Werewolf Therapeutics to Participate in the Upcoming H.C. Wainwright 27th Annual Global Investment Conference
• 08.14.2025 - Werewolf Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update
• 08.14.2025 - Werewolf Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update
• 07.09.2025 - Werewolf Therapeutics to Participate in the KidneyCAN 7th Annual Kidney Cancer Research Summit
• 07.09.2025 - Werewolf Therapeutics to Participate in the KidneyCAN 7th Annual Kidney Cancer Research Summit

Recent Filings

• 08.14.2025 - 8-K Current report
• 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.14.2025 - EX-99.1 EX-99.1
• 08.14.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 06.13.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.13.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.13.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.13.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.13.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.13.2025 - 4 Statement of changes in beneficial ownership of securities